Latest Bavarian Nordic News & Updates

See the latest news and media coverage for Bavarian Nordic. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Bavarian Nordic

Biopharmaceutical vaccine company

bavarian-nordic.com
Headquarters
Copenhagen, Denmark
Founded year
1994
Company type
Public company
Number of employees
1,700–5,000

Last updated

Latest news about Bavarian Nordic

In short: Bavarian Nordic reported strong 2025 revenue of DKK 6.2 billion, initiated a CEO transition, and secured a major Canadian mpox vaccine contract.

Company announcements

  • Bavarian Nordic

    Bavarian Nordic delivers first mpox vaccine shipment to Mexico

    The delivery through PAHO partnership strengthens Mexico's public health readiness for potential outbreaks.

  • Bavarian Nordic

    Bavarian Nordic welcomes new board members

    Shareholders elect three new members and re-elect five at the Annual General Meeting. The board gains expertise in life sciences and finance.

  • Bavarian Nordic

    Bavarian Nordic holds Annual General Meeting

    The meeting adopts the 2025 Annual Report, discharges the Board, elects new directors including Anne Louise Eberhard as Chair, approves share authorizations, but rejects Remuneration Report indicatively.

  • Bavarian Nordic

    Bavarian Nordic receives Swissmedic approval for chikungunya vaccine

    Swissmedic approves VIMKUNYA® for individuals aged 12 years and above. This marks the fourth approval following FDA, EMA, and MHRA in 2025.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Bavarian Nordic

Track Bavarian Nordic and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Bavarian Nordic competitors & trending companies

Browse news for competitors to Bavarian Nordic and other trending companies.